02/07/2024 Healthcare
CLAVSAT-375 tablets combine Amoxicillin and Potassium Clavulanate, offering a potent antibiotic therapy. Amoxicillin, a penicillin derivative, inhibits bacterial cell wall synthesis. Potassium Clavulanate enhances Amoxicillin's efficacy by inhibiting bacterial beta-lactamase enzymes that can degrade Amoxicillin. This combination treats a wide range of bacterial infections, including respiratory tract infections and urinary tract infections, ensuring effective bacterial eradication and reducing the risk of antibiotic resistance.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations
CLAVSAT-375 tablets combine Amoxicillin and Potassium Clavulanate, offering a potent antibiotic therapy. Amoxicillin, a penicillin derivative, inhibit...
Amoxicillin & Potassium Clavulanate Oral Suspension IP, branded as Clavsat DRY SYRUP, is a combination antibiotic used to treat various bacterial ...
"CLAVSAT-625 tablets combine Amoxicillin and Potassium Clavulanate to treat bacterial infections effectively. Amoxicillin, a penicillin antibiotic, in...
**Stapolin-CV** combines Cefpodoxime Proxetil and Potassium Clavulanate in tablet form, enhancing antibacterial efficacy. Cefpodoxime, a third-generat...
More Details